Keryx Biopharmaceuticals Inc fka KERX

[FredKerx]

Fellow investors, in my opinion, questions arise concerning if what we were fed by Madison/Holmes 2-21/2 years ago was a total croc? IMO, questions arise concerning if Keryx ever had any intentions of partnering in EU during past years since EU approval? Again, imo, it goes back to hypo scenario Keryx/AMAG/Rockwell Medical - “sequence of events...during past some 4 years and as we speak, are interrelated. In other words, Keryx’s development/true advancement as a company during past years has not been truly independent, but rather in function to some degree of AMAG and Rockwell Medical and, at the core, timeframe involved while and until generics FDA approved and launched.”

Now, imo, what Keryx HAS done during past years since EU approval is lay groundwork for when the time arrived to implement EU, as have posted in past in reference to Fexeric EU internet due diligence found in following post..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139373421

So, where is this going? IMO, potentially, Keryx will now surface an EU deal, 21/2 years later, as part of “a plan”. The EU announcement, if realized, would potentially serve as “next step” and represent an opportunity to tout “an accomplishment” and “distract” in midst of ongoing machinations as per hypo scenario - conjecturing, calculated “next step” to sorta “throw sand” at damage consummated (i.e. pps sub-$5 since IDA approval going on 5 MONTHS, nevermind the past years). Also, sorta “camouflage” underlying bigger picture which, so goes hypothetical, responds to ownership control, potential merger with AMAG which in turn serves as route to overcome Baupost/Abrams as an obstacle, prior to “takeunder” at cheap.

ALL, in my opinion, hypothesizing, thinking out loud, conjecturing if you will.